Your session is about to expire
← Back to Search
1 for Cardiovascular Disease
Phase 1
Waitlist Available
Led By Diane K. Deitz, PhD
Research Sponsored by National Heart, Lung, and Blood Institute (NHLBI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Works in participating company
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured pre- and post-intervention
Awards & highlights
Study Summary
Heart disease is the leading cause of death in the United States, accounting for approximately 700,000 deaths a year. Heart disease can take many forms, including heart attacks, coronary artery disease, aneurysms, high blood pressure, and strokes. However, people can change things in their life to reduce the risk of getting heart disease. This study will first create an Internet-based program to help teach people about reducing heart disease risk and will then test the program in a workplace setting.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured pre- and post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured pre- and post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in health attitudes and behaviors
Secondary outcome measures
Change in cardiovascular risk status
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Participants will use the Web-based Heart Healthy program.
Group II: 2Active Control1 Intervention
Participants will receive treatment as usual.
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)Lead Sponsor
3,836 Previous Clinical Trials
47,850,748 Total Patients Enrolled
National Institute for Occupational Safety and Health (NIOSH/CDC)FED
41 Previous Clinical Trials
49,239 Total Patients Enrolled
Diane K. Deitz, PhDPrincipal InvestigatorISA Associates
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger